comparemela.com
Home
Live Updates
Innocan Pharma Corporation: Innocan Reports Positive Results
Innocan Pharma Corporation: Innocan Reports Positive Results
Innocan Pharma Corporation: Innocan Reports Positive Results from Recent Preclinical Trial on Epileptic Seizures On a Dog using LPT: Since The Last LPT injection, Paco (dog) Has Not Had a Seizure for Over 10 weeks
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 6, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce positive results
Related Keywords
Jerusalem ,
Israel General ,
Israel ,
Herzliya ,
Tel Aviv ,
Canada ,
Hebrew University ,
Yerushalayim ,
Canadian ,
Iris Bincovich ,
Chezy Barenholz ,
Innocan Pharma ,
Development Company Yissum ,
Company Or Innocan ,
Innocan Pharma Corporation ,
Liposome Research Department ,
Market Research ,
Innocan Pharma Ltd ,
Hebrew University Of Jerusalem ,
Alberta Newsfile Corp ,
Tel Aviv University ,
Yissum Research ,
Pharma Corporation ,
Liposome Platform ,
Allied Market Research ,
Global Anti Epilepsy Drugs Market Size ,
Market Watch ,
Pharma Ltd ,
Development Company ,
Professor Chezy Barenholz ,
Professor Barenholz ,
Innocan ,
Dharma ,
Corporation ,
Reports ,
Positive ,
Results ,
Rom ,
Ecent ,
Reclinical ,
Trial ,
Epileptic ,
Seizures ,
Sing ,
Rince ,
Mast ,
Injection ,
Waco ,
Seizure ,
Dover ,
Eeks ,